This formulation has been found to benefit acute asthma, fatigue, migraines, chronic fatigue syndrome, fibromyalgia, acute muscle spasm, upper respiratory tract infections, chronic sinusitis, seasonal allergic rhinitis, cardiovascular disease, and more
They cut out nearly half their food
"But what we are seeing is that GLP-1 coverage is getting more accessible for specific conditions sleep apnea, diabetes, extremely high BMI or a combination of these things but for other conditions, coverage is probably going to get more restrictive
You can typically resume your normal activities immediately after the treatment
In clinical trials of Wegovy as an adjunct to lifestyle modification, participants lost an average of 15 percent of their body weight with more than half the people treated with Wegovy losing more than 15 percent of their starting weight - up to five times the average weight loss seen with traditional diet and exercise plans
The global prevalence of obesity has risen sharply, with recent pooled analyses showing widespread increases across 200+ countries over the past three decades[3]
